Raynard Bateman
Affiliations: | 2002-2006 | Cellular and Molecular Pharmacology | University of California, San Francisco, San Francisco, CA |
Google:
"Raynard Bateman"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bateman RL, Rauh D, Tavshanjian B, et al. (2008) Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. The Journal of Biological Chemistry. 283: 35756-62 |
Bateman R, Rauh D, Shokat KM. (2007) Glutathione traps formaldehyde by formation of a bicyclo[4.4.1]undecane adduct. Organic & Biomolecular Chemistry. 5: 3363-7 |
Estébanez-Perpiñá E, Arnold LA, Arnold AA, et al. (2007) A surface on the androgen receptor that allosterically regulates coactivator binding. Proceedings of the National Academy of Sciences of the United States of America. 104: 16074-9 |
Bateman RL, Ashworth J, Witte JF, et al. (2007) Slow-onset inhibition of fumarylacetoacetate hydrolase by phosphinate mimics of the tetrahedral intermediate: kinetics, crystal structure and pharmacokinetics. The Biochemical Journal. 402: 251-60 |
Estébanez-Perpiñá E, Arnold LA, Nguyen P, et al. (2007) Erratum: A surface on the androgen receptor that allosterically regulates coactivator binding (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, 41, (16074-16079) DOI: 10.1073/pnas. 0708036104) Proceedings of the National Academy of Sciences of the United States of America. 104 |
Wei W, Bateman R, Rauh D, et al. (2006) P0119. Pharmacological inhibitors of S-nitroso-glutathione reductase Nitric Oxide. 14: 55-56 |
Tanaka M, Bateman R, Rauh D, et al. (2005) An unbiased cell morphology-based screen for new, biologically active small molecules. Plos Biology. 3: e128 |
Kunkel EJ, Plavec I, Nguyen D, et al. (2004) Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models. Assay and Drug Development Technologies. 2: 431-41 |